Oxytocin Acetate

FDA Approved

Cyclic nonapeptide

Oxytocin is a nonapeptide hormone produced in the hypothalamus and released by the posterior pituitary. It has been extensively studied in neuroscience and endocrinology research for its roles in social bonding, reproductive physiology, and maternal behavior. Published research has examined its receptor binding, signaling pathways, and distribution in various tissues. RaysunPeptide supplies Oxytocin Acetate for qualified research and laboratory applications.

Mechanism of Action

Binds oxytocin receptors on uterine smooth muscle, triggering calcium influx and myometrial contractions. Stimulates prostaglandin release. In CNS, modulates GABAergic, serotonergic, dopaminergic neurotransmission; reduces cortisol and HPA axis activity.

Key Benefits

1FDA-approved for labor induction with precise dosing via IV
2Immediate onset in obstetric settings
3Established safety profile in clinical use
4Researched for anxiety, PTSD, autism, sexual dysfunction

Molecular Data

Molecular Weight
1,007.19 Da
Half-Life
3-6 minutes
Chain Length
9 amino acids
Amino Acid Sequence
CYIQNCPLG-NH2

Dosing Protocols

GoalDoseFrequencyRoute
Labor Induction0.5-2 mU/min initial, titrate to 1-2 mU/min every 30-60 minContinuous IV infusionIV (diluted)
Postpartum Hemorrhage Prevention10 units IM or 10-40 units in IV solutionSingle dose after placental deliveryIM or IV infusion

Research Indications

Obstetric (FDA Approved)

Labor Inductionmost effective

Initiates or augments uterine contractions when vaginal delivery medically indicated.

Postpartum Hemorrhage Controlmost effective

Controls postpartum bleeding through uterine contraction stimulation during third stage.

Incomplete Abortion Managementeffective

Adjunctive therapy for incomplete or inevitable abortion in second trimester.

Research/Emerging

Autism Spectrum Disordersmoderate

Extensive research with mixed results on social functioning; optimal dosing unclear.

PTSD Augmentationeffective

Combined with exposure therapy; shows reduced PTSD/depression symptoms.

Social Anxietymoderate

Decreases amygdala reactivity to social threats; normalizes brain connectivity.

Sexual Functioneffective

Improves libido, arousal, orgasm intensity in both sexes.

Peptide Interactions

Vasopressin (AVP)~ monitor

Structurally similar; overlapping receptor affinity with potential additive effects.

Selank++ synergistic

Complementary anxiolytic effects—Selank modulates GABA; oxytocin acts on central receptors.

PT-141 (Bremelanotide)++ synergistic

Complementary sexual function effects via different pathways.

Kisspeptin++ synergistic

Both involved in reproduction; kisspeptin stimulates GnRH; oxytocin enhances arousal.

BPC-157+ compatible

No direct interactions; different mechanisms (tissue repair vs social function).

SSRI Antidepressants~ monitor

SSRIs may affect endogenous oxytocin; combined use requires healthcare provider oversight.

Alcohol! avoid

Alcohol suppresses oxytocin release; reduces therapeutic effects.

What to Expect

1
Injectable
IV: 1-3 minute onset, 30-60 minute duration; IM: 3-5 minute onset
2
Intranasal
15-30 minute onset, peak 30-60 minutes, 2-4 hour duration
3
Sublingual
30-45 minute onset, peak ~60 minutes, 2-4 hour duration

Side Effects & Safety

Common (Generally Mild)

  • •Mild headache
  • •Nasal irritation (intranasal)
  • •Nausea or vomiting
  • •Transient blood pressure changes

Stop Signs (Seek Medical Attention)

  • ⚠Uterine hyperstimulation or fetal distress (injectable)
  • ⚠Severe or persistent headache
  • ⚠Signs of water intoxication (confusion, seizures, swelling)
  • ⚠Severe nasal irritation or bleeding
  • ⚠Allergic reaction (rash, breathing difficulty)

Contraindications

  • ✕Certain obstetric conditions (see prescribing info)
  • ✕Pregnancy (without medical supervision)
  • ✕Active sinus infection (intranasal)
  • ✕Severe hyponatremia

Quality Checklist

Good Signs ✓

  • FDA-approved pharmaceutical product from licensed pharmacies (injectable)
  • Clear, colorless solution without particles or discoloration
  • Proper packaging with verified lot number, expiration, concentration
  • Licensed compounding pharmacy source with USP compliance

Warning Signs !

  • Variable compounding quality between pharmacies
  • Nasal congestion reduces intranasal absorption
  • Sublingual has lower bioavailability than intranasal

Bad Signs ✕

  • Cloudy, discolored, or particulate solution
  • From unlicensed or unverified sources
  • Improper storage or broken cold chain

References

Intranasal Oxytocin in Autism Spectrum Disorder
• • 2021

N=290 children/adolescents; 48 IU daily; 24 weeks. Did not significantly improve social functioning vs placebo; highlights need for better patient selection.

Oxytocin Augmented Prolonged Exposure Therapy for PTSD
• • 2019

Veterans with PTSD; 40 IU intranasal combined with PE therapy. Lower PTSD and depression symptoms; higher therapeutic alliance vs placebo.

Intranasal Oxytocin for Obesity
• • 2024

N=61 adults with obesity; 24 IU four times daily; 8 weeks. No weight loss but significant reduction in caloric intake; improved mental health-related quality of life.

FAQs

Does intranasal oxytocin actually improve social anxiety, or is it just a placebo?

Research shows oxytocin decreases amygdala reactivity to social threats and normalizes brain connectivity related to social processing. It's not a placebo, but it's not a miracle either. The effects are measurable in brain imaging and behavioral tests, though the magnitude varies between individuals.

Can I use oxytocin for sexual function without a medical reason?

Yes, it's researched for sexual enhancement—the file lists sexual function as an indication with 24-40 IU taken 30-45 minutes before activity. However, it's FDA-approved only for obstetric use.

Will alcohol interfere with oxytocin's effects?

Yes. Alcohol suppresses endogenous oxytocin release, which would significantly reduce any therapeutic or enhancement benefits.

How is intranasal oxytocin different from the obstetric injection?

The obstetric injection (FDA-approved Pitocin) is high-dose IV for labor induction with immediate onset and precise dosing control. Intranasal oxytocin delivers much lower doses and achieves brain delivery via olfactory pathways with slower onset (15-30 minutes) but longer duration (2-4 hours).

Oxytocin Acetate

Dosing Summary

Dose
Intranasal: 20-24 IU; Injectable: 10-40 IU; Sublingual: 50-100 IU
Frequency
As needed for social/sexual support, or 1-2x daily for anxiety/PTSD protocols; max 1 dose per 24hr for sexual function
Cycle
As needed for research applications; 4-12 weeks for anxiety/autism protocols
Storage
Refrigerate at 2-8°C; protect from light

Specifications

Purity≥98% (HPLC verified)
FormLyophilized powder
Packaging2mg / 5mg / 10mg
StorageStore at -20°C, protect from light
Catalog No.OT2 / OT5 / OT10

Research Data

3
Studies
2024
Latest
3
Recent

Available Sizes

2mg$20
5mg$22